Last update Dec. 2, 2022
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
HM02AW5004; HR05WA5008; HR05WA5009; HR05WA5010; R05CA13 is Eucalyptus in ATC Code/s.Is written in other languages:
HM02AW5004; HR05WA5008; HR05WA5009; HR05WA5010; R05CA13 is also known as
HM02AW5004; HR05WA5008; HR05WA5009; HR05WA5010; R05CA13 belongs to these groups or families:
Main tradenames from several countries containing HM02AW5004; HR05WA5008; HR05WA5009; HR05WA5010; R05CA13 in its composition:
Write us at email@example.com
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
The leaves are the part of the tree that is used. They contains essential oil (1,8-cineole or eucalyptol, globulol, trans-pinocarveol, α-terpineol, cymen, α-pinene and β-pinene), hydrocyanic acid, tannins, terpenes, flavonoids and phenolic acids (phytotherapy.net). Attributed Properties: Systemic use: expectorant, mucolytic; topical use: antiseptic, anti-inflammatory and healing. The European Medicines Agency (EMA 2014) and Commission E (Blumenthal 1998) approve its oral use to treat cold symptoms and its topical use for localized muscle and joint pain. Oral, dermal and inhalation administration.
At the date of the last update, the authors did not find any published data on its excretion in breast milk.
Various components of eucalyptus are excreted in breast milk and confer a characteristic odor and flavor to milk that could be perceived by the infant. (Debong 2020, Spahn 2019, Kirsch 2012)
Eucalyptol has no suppressive activity on breast epithelial cells. (Suzuki 2020)
Eucalyptol is neurotoxic and convulsive (Burkhard 1999). Overdosing of essential oil can cause severe neurological depression in adults and children. (Hale, Waldman 2011, Halicioglu 2011, Darben 1998, Webb 1993, Patel 1980)
The European Medicines Agency contraindicated it in children with a history of seizures and in children under 30 months and did not recommend it in children under 4 years and during breastfeeding. (EMA 2014)
Due to the toxicity of its essential oil, it is not prudent to use it during breastfeeding outside of occasional and moderate use.
Topical use is compatible with breast-feeding as long as it is not applied to the breast.